Factors associated with the initiation of biologic disease modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis
Rheumatoid arthritis (RA) is a progressive autoimmune disorder of joints that is associated with high health care costs and yet lacks guidance on how early to initiate biologic disease-modifying antirheumatic drugs (DMARDs), a class of medications that is the major cost driver in RA management. The...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en |
| Published: |
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2152/26475 |